ESPR · Esperion Therapeutics, Inc.

Market Cap

$818.63M

257.43M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sheldon L. Koenig	President and Chief Executive Officer	$770,833	—	$1,260,000	$847,929	$639,375	$17,375	$3,535,512
John B. Harlow	Chief Commercial Officer	$66,875	$35,000	$1,608,991	$1,101,468	—	$769	$2,813,103
Benjamin Halladay	Chief Financial Officer	$495,833	—	$357,000	$239,852	$247,500	$11,750	$1,351,935

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sheldon L. Koenig	President and Chief Executive Officer	$745,833	—	$930,700	$982,162	$487,500	$29,045	$3,175,240
Joanne Foody	Chief Medical Officer	$388,288	—	$307,500	$383,711	$195,200	$595,860	$1,870,559
Benjamin Halladay	Chief Financial Officer	$467,333	—	$348,500	$305,969	$235,125	$11,500	$1,368,427
Eric Warren	Chief Commercial Officer	$481,867	—	$205,000	$229,477	$218,250	$15,250	$1,149,844
Benjamin Looker	General Counsel	$471,000	—	$205,000	$229,477	$213,750	$11,600	$1,130,827

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sheldon L. Koenig	President and Chief Executive Officer	$720,833	—	$422,100	$1,267,661	$541,938	$16,033	$2,968,565
Joanne Foody	Chief Medical Officer	$528,333	—	$115,575	$452,295	$306,475	$22,063	$1,424,741
Eric Warren	Chief Commercial Officer	$462,500	—	$89,646	$269,200	$241,259	$15,100	$1,077,705

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sheldon L. Koenig	President and Chief Executive Officer	$683,333	—	$549,840	$2,052,139	$500,500	$13,600	$3,799,412
Joanne Foody	Chief Medical Officer	$505,000	—	$132,720	$627,248	$249,975	$16,216	$1,531,159
Benjamin Looker	—	$375,000	—	$258,420	$485,002	$165,000	$10,350	$1,293,772

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tim Mayleben	Former Chief Executive Officer	$265,152	—	—	$3,986,245	—	$3,975,889	$8,227,286
Sheldon L. Koenig	President and Chief Executive Officer	$565,909	—	$1,619,698	$5,427,619	$150,000	$13,000	$7,776,226
Joanne Foody	Chief Medical Officer	$258,239	$100,000	$1,608,834	$1,603,426	$113,625	—	$3,684,124
Richard Bartram	Former Chief Financial Officer	$411,667	—	$922,306	$1,895,559	$84,000	$9,750	$3,323,282
Ashley Hall	Former Chief Development Officer	$270,063	—	$650,468	$1,134,130	—	$822,588	$2,877,249

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tim Mayleben	Former Chief Executive Officer	$700,000	—	$1,420,021	$4,518,084	$210,000	$76,919	$6,925,024
Richard Bartram	Former Chief Financial Officer	$400,000	—	$461,584	$1,470,247	$120,000	$9,750	$2,461,581
Mark Glickman	Former Chief Commercial Officer	$453,409	—	$363,440	$1,154,730	—	$382,000	$2,353,579
Ashley Hall	Former Chief Development Officer	$435,000	$300,000	$337,370	$1,073,411	$145,000	$9,750	$2,300,531
Sheldon L. Koenig	President and Chief Executive Officer	$23,182	—	—	—	—	—	$23,182

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tim Mayleben	Former Chief Executive Officer	$625,000	—	—	—	$375,000	$80,850	$1,080,850
Mark Glickman	Former Chief Commercial Officer	$440,000	—	—	—	$176,000	$8,392	$624,392
Richard Bartram	Former Chief Financial Officer	$340,000	—	—	—	$136,000	$9,500	$485,500

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tim Mayleben	President and Chief Executive Officer	$600,000	$115,000	—	$8,568,224	$360,000	$81,615	$9,724,839
Mark Glickman	Former Chief Commercial Officer	$322,500	—	$1,345,800	$7,147,108	$190,000	$9,250	$9,014,658
Richard Bartram	Chief Financial Officer	$330,000	—	—	$2,110,673	$90,000	$9,250	$2,539,923

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tim Mayleben	President and Chief Executive Officer	$557,500	—	—	$3,962,187	$404,000	$89,773	$5,013,460

Executive changes

Person	Role	Change	Effective	Filed
Sheldon L. Koenig	Class I director	Appointed	2026-05-28	2026-06-01
J. Martin Carroll	Class I director	Appointed	2026-05-28	2026-06-01
John B. Harlow, Jr.	Chief Commercial Officer	Appointed	2025-11-17	2025-11-04
Craig Thompson	Class II director	Appointed	2025-07-01	2025-07-01
Seth H.Z. Fischer	Class III director	Appointed	2025-05-29	2025-06-02
Jay P. Shepard	Class III director	Appointed	2025-05-29	2025-06-02
Robert E. Hoffman	Class II director	Appointed	2025-04-01	2025-04-01
Antonio M. Gotto, Jr., M.D., D. Phil.	member of the Board	Resigned	2025-06-01	2025-04-01
Nicole Vitullo	member of the Board	Resigned	2025-06-01	2025-04-01
Nicole Vitullo	Class II Director	Appointed	2024-05-23	2024-05-28
Antonio M. Gotto Jr., M.D., D.Phil.	Class II Director	Appointed	2024-05-23	2024-05-28
Tracy Woody	Chairperson of the Compliance Committee of the Board	Appointed	2023-06-15	2023-06-15
Jeffrey Berkowitz	director	Resigned	2023-06-15	2023-06-15
Ben Halladay	Chief Financial Officer	Appointed	2022-11-16	2022-11-16
Benjamin Halladay	Chief Financial Officer	Appointed	2022-11-16	2022-11-16
Sheldon L. Koenig	President & Chief Executive Officer	Appointed	2022-06-09	2022-06-13
J. Martin Carroll	Chairperson of the Board	Appointed	2022-06-01	2022-06-01
J. Martin Carroll	Class I director	Appointed	2022-06-01	2022-06-01

Key facts CIK 1434868 CUSIP 29664W105 13F (30d) 180 filings 177 filers Visit website Investor relations